|
ASU's Biodesign Institute and ImmuneRegen Collaborate to Investigate Possible Enhancement of Vaccine Against Norwalk Viruses ImmuneRegen® BioSciences Confirms Homspera® Advances Wound Healing in Topical Application IR BioSciences Holdings, Inc. Closes New $5 Million Funding Round ImmuneRegen(R) BioSciences Advances Toward IND Filing ImmuneRegen® BioSciences Confirms Adult Stem Cell Activity of Homspera® in Human Bone Marrow
|
We are excited to share with you that Immuneregen Biosciences has been nominated by the Vaccine Industry Excellence Awards as the Best Vaccine Start-up Company. This nomination adds to all of the great progress we have been making as a company and reconfirms our impact in the industry.
PLEASE NOTE: Our ticker symbol changed to IRBS on August 1, 2008.
for job opportunities, |
